More and more, researchers are making discoveries that are bringing us closer to finally combating this most insidious of diseases. Sometimes termed a disease of the caregiver, Alzheimer’s continues to ravage the memories of it’s victims. Dr. Danillo de la Pena, Director of the Research Center for Clinical Studies in Norwalk CT, pharmaceutical-sponsored clinical research in neuropsychiatric disorders. We discussed progress made and why so much recent activity has been seen. Dr. de la Pena also discusses the process of Clinical Studies and puts to rest some misinformation.
Rare Sharing of Data Leads to Progress on Alzheimer’s
New Guidelines For Diagnosing Alzheimer’s-Wishful Thinking, Dangerous Consequences
Spinal-Fluid Test Is Found to Predict Alzheimer’s
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Understanding Clinical Trials
What to Tell the Patients After a Trial Goes Awry
The Research Center for Clinical Studies, Inc.